Project Grant HT94252411065
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$577K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $777,927 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will support research into targeting PARP signaling as a novel treatment for urologic complications of spinal cord injury from August 15, 2023 through August 14, 2026. The Military Medical Research and Development program aims to advance biomedical solutions for battlefield...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $796,500 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to investigate clonal evolution in Fanconi anemia. The grant period runs from September 30, 2023 to September 29, 2026. As a non-profit pediatric teaching hospital and research center, Boston Children's Hospital will leverage its expertise in pediatric medicine, genomics, and...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...
The Department of the Army Medical Command awarded a $3,062,579 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation (Boston Children's Hospital) on April 15, 2025. The grant supports an integrated research approach to identify biopsychosocial aspects of pain in fibrous dysplasia/McCune-Albright syndrome, a rare genetic condition, over a performance period ending on April 14, 2029. Boston Children's Hospital, a...
The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...
The federal Project Grant award of $1,068,000.00 from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) will support research conducted by The Children's Hospital Corporation (doing business as Boston Children's Hospital) to activate gasdermin pores and induce pyroptosis, a form of programmed cell death, in order to stimulate antitumor immunity in ovarian cancers. The research project will run from April 15, 2025 to April 14, 2028 and...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $796,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2021 through June 2024 to investigate the contribution of rapamycin-insensitive processes to neurological symptoms in tuberous sclerosis complex. The Military Medical Research and Development program aims to advance biomedical...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $367,969 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support the development of human inner ear organ-on-chip platforms for hearing loss drug discovery from September 1, 2021 through August 31, 2023. The organ-on-chip technology focuses on transforming healthcare for service members and the...
The Defense Health Agency awarded a $1,000,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to support research on the "Diversity of Memory B Cells in Lupus". The 4-year grant, with a period of performance from September 1, 2024 to August 31, 2028, will enable Boston Children's Hospital to conduct biomedical research focused on understanding the role of...